1. Morin L, Vetrano DL, Rizzuto D, Calderón-Larrañaga A, Fastbom J, Johnell K. Choosing wisely? Measuring the burden of medications in older adults near the end of life: nationwide, longitudinal cohort study. The American Journal of Medicine. 2017.
http://linkinghub.elsevier.com/retrieve/pii/S000293431730253X
. Accessed 6 May 2017.
2. Alzner R, Bauer U, Pitzer S, Schreier MM, Osterbrink J, Iglseder B. Polypharmacy, potentially inappropriate medication and cognitive status in Austrian nursing home residents: results from the OSiA study. Wien Med Wochenschr. 2016;166(5–6):161–5.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD). The global strategy for the diagnosis, management and prevention of COPD. 2017.
http://goldcopd.org
. Accessed 9 May 2017, Chapter 6.
4. Riesinger R, Iglseder B. Tools zur Therapieoptimierung bei multimorbiden geriatrischen Patienten am Lebensende – Hilfe oder „nur“ Denkanstoß? Wien Med Wochenschr. 2014;164(9–10):189–94.
5. Roblek T, Vaupotic T, Mrhar A, Lainscak M. Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol. 2015;71(2):131–42.